WNY Asset Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
WNY Asset Management's GILD Position: Q3 2025 in Review
WNY Asset Management sold out of Gilead Sciences (GILD) in Q3 2025, closing a stake of 5,692 shares — an estimated $631K sold.
WNY Asset Management first reported a position in GILD in Q1 2021 and held it in 18 quarters. The position peaked at $3.63M in Q2 2024. 2,026 funds tracked by Wall St. Rank hold GILD as of Q3 2025.
- WNY Asset Management reported no remaining Gilead Sciences position as of Q3 2025 after selling out during the quarter.
- WNY Asset Management sold 5,692 Gilead Sciences shares in Q3 2025, an estimated $631K.
- WNY Asset Management first reported a position in Gilead Sciences in Q1 2021 and held it in 18 quarters.
- WNY Asset Management's Gilead Sciences position peaked at $3.63M in Q2 2024.
- 2,026 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2025.
Based on WNY Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.